Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: OBSERVATIONAL
Official Title: Multicenter Safety Evaluation of Human Rabies Immune Globulin 300 IU/mL in Children
Brief Summary: This observational study will be conducted across the Houston Methodist system, including all hospital-based and freestanding emergency departments (ED), and up to 4 additional sites in the United States.
The safety of human rabies immune globulin (HRIG) 300 IU/mL product (HyperRAB�) in pediatric patients has not been fully established.
The purpose of this study is to evaluate the safety of HRIG 300 IU/mL when given to pediatric patients per standard of care for rabies postexposure prophylaxis (PEP) in the ED.